Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Rouaz, Khadija et al., 2021
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/176690

Excipients in the Paediatric Population: A Review

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

Resum

This theoretical study seeks to critically review the use of excipients in the paediatric population. This study is based on the rules and recommendations of European and American drug regulatory agencies. On the one hand, this review describes the most frequent excipients used in paediatric medicine formulations, identifying the compounds that scientific literature has marked as potentially harmful regarding the side effects generated after exposure. On the other hand, this review also highlights the importance of carrying out safety -checks on the excipients, which, in most cases, are linked to toxicity studies. An excipient in the compilation of paediatric population databases is expected to target safety and toxicity, as in the STEP database. Finally, a promising pharmaceutical form for child population, ODT (Orally Disintegrating Tablets), will be studied.

Citació

Citació

ROUAZ EL HAJOUI, Khadija, et al. Excipients in the Paediatric Population: A Review. Pharmaceutics. 2021. Vol. 13, num. 3, pags. 387. ISSN 1999-4923. [consulted: 15 of August of 2026]. Available at: https://hdl.handle.net/2445/176690

Exportar metadades

JSON - METS

Compartir registre